Gerry H. Visser
The Netherlands
University Medical Center, Utrecht
International Foundation for Maternal Periconceptional and Peri- neonatal Medicine (FIMPP) founded by a group of highly professional and enthusiastic obstetricians and neonatologists, the worldwide known experts in the field that aim to revive the interest around maternal and neonatal care.
FIMPP is composed of Board of Directors, chaired by Prof. Gian Carlo Di Renzo from Italy and Board of Scientific Advisors, chaired by Prof. Umberto Simeoni from Switzerland.
The purpose of FIMPP is to foster education, research and advocacy in maternal, periconceptional and neonatal medicine and care worldwide. The Foundation aims to promote and disseminate the study, research and knowledge on the aspects of maternal, periconceptional and neonatal medicine, in order to attain, by appropriate means, a higher level of physical and mental health for women,
mothers, and their children.
Collaboration between various disciplines interested in maternal, perception, and perinatal care as well as friendship between individuals from different world countries will lead to improving the quality and provision of care in the world.
Neena Modi
United Kingdom
Imperial College London
Gerry H. Visser
The Netherlands
University Medical Center, Utrecht
Liona Poon
Hong Kong
The Chinese University of Hong Kong
Maximo Vento Torres
Spain
University & Polytechnic Hospital La Fe
Gian Carlo Di Renzo (Chair)
Italy
University of Perugia
Eduardo Bancalari
United States
University of Miami
Despina Briana
Greece
Athens University Medical School
Eduardo Fonseca
Brazil
Federal University of Paraiba
Sepsis in children is a complex syndrome that develops from various infections and results in 15-30% mortality in high-income countries and up to 50% or higher in low-income countries. Worldwide, this represents an annual burden of 30 million cases resulting in 8 million deaths. Not surprisingly, there is a significantly higher burden in low-income countries with children there being 18 times more likely to die before the age of 5 years compared to high-income countries. Factors such as commercial air travel, climate change, and unchecked population growth have contributed to the growing burden of infectious diseases and ensuing sepsis. Improving public awareness of sepsis; increasing access to essential medicines and vaccines; improving use of evidence-based treatment guidelines; raising awareness of antimicrobial resistance, encouraging antibiotic stewardship; and, developing resilient health systems that can cope with health crises are all important challenges. Advocacy in these areas can assist nations in reaching the United Nations Sustainable Development Goals (UN SDGs) of low rates of neonatal and under-5 mortality.
On May 26, 2017, the World Health Assembly, the decision-making body of the World Health Organization, adopted a resolution proposed by the Global Sepsis Alliance to improve the prevention, diagnosis, and management of sepsis.The resolution highlights sepsis as a global threat and urges the 194 United Nations member states to take specific actions and implement appropriate measures to reduce its human and health economic burden. The resolution is a major step toward achieving the targets outlined by the Sustainable Developmental Goals for decreasing mortality in infants and children, but implementing it will require a concerted global effort.
update on number of registrants: 18/50 (sept 29th)
€ 150,00
update on number of registrants: 17/50 (sept 29th)
€ 150,00
update on number of registrants: 12/50 (sept 29th)
€ 150,00
update on number of registrants: 7/50 (sept 29th)
€ 150,00
update on number of registrants: 18/60 (sept 29th)
€ 150,00
update on number of registrants: 32/60 (sept 29th)
€ 150,00